BDSX
Biodesix, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.18
−1.11%Margins
Gross margin
82.5%
EBITDA margin
-13.9%
EBIT margin
-20.0%
Net margin
-27.0%
FCF margin
-19.8%
-303.6%
Return on equity
-29.1%
Return on assets
-25.4%
Return on invested capital
1.08x
Asset turnover
-$19.8M
Cash from operations
$2.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026